Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2003
04/08/2003US6544196 Estrogen or estradiol need determination by vaginal or urethral acidity determination
04/08/2003US6543931 Method of evaluating the glass-transition temperature of a polymer part during use
04/08/2003US6543657 Thermal manikin
04/08/2003US6543551 Pipe handling device
04/08/2003US6543274 Sensor array and method for determining the density and viscosity of a liquid
04/08/2003CA2257735C Molten metal probe
04/08/2003CA2244111C Method and apparatus for multi-spectral analysis in noninvasive nir spectroscopy
04/08/2003CA2219176C Improved diagnostic detection device
04/08/2003CA2205015C Method for producing biologicals in protein-free culture
04/08/2003CA2184584C Vascular endothelial growth factor 2
04/08/2003CA2163524C Assay and reagents for identifying anti-proliferative agents
04/08/2003CA2127470C Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis
04/08/2003CA2109193C Gaba-a receptor subunits (.alpha.-2,.alpha.-3,.alpha.-5,.alpha.-6,.beta.-2) and transfected cells expressing them
04/08/2003CA2107732C Retrovirus from the hiv group and its use
04/08/2003CA2098584C Method for determining resin particles in paper stocks
04/08/2003CA2091764C Probe compositions for chromosome identification and methods
04/08/2003CA2087476C Pretreatment of sample for endotoxin measurement
04/08/2003CA2050677C Visual blood glucose concentration test strip
04/08/2003CA2021587C Automated method and device for performing solid-phase diagnostic assay
04/08/2003CA2006332C Method of detecting neurological disease or dysfunction
04/03/2003WO2003028271A2 Methods of using quantitative lipid metabolome data
04/03/2003WO2003027927A1 Dna providing system
04/03/2003WO2003027716A1 In situ method for determining soil liquefaction tendency and its prevention by electro-osmosis
04/03/2003WO2003027682A2 Controlling isotope effects during fractionation of analytes
04/03/2003WO2003027681A2 A method of protein analysis
04/03/2003WO2003027680A2 Makrophage-based biosensor for detection of toxic substances
04/03/2003WO2003027679A1 Method and biosensor for analysis
04/03/2003WO2003027678A1 Fluorescence proximity assay
04/03/2003WO2003027677A2 Method of attachment of a biomolecule to a solid surface
04/03/2003WO2003027676A1 Fluorescence biosensor chip and fluorescence biosensor chip arrangement
04/03/2003WO2003027675A1 Fixed support for immobilizing biomolecules
04/03/2003WO2003027674A1 Support for ligand immobilization
04/03/2003WO2003027673A1 Gene inspection apparatus and target nucleic acid extraction method using the same
04/03/2003WO2003027672A1 Novel screening method using prokineticin receptor
04/03/2003WO2003027671A2 Apoptosis
04/03/2003WO2003027670A1 Device and method for detecting defects in a wood or wood-based product from its acoustic signature
04/03/2003WO2003027669A2 Method for producing a normalized gene library from nucleic acid extracts of soil samples and the use thereof
04/03/2003WO2003027668A1 Method for reducing damage to heating plants and device for carrying out said method
04/03/2003WO2003027667A1 Method and detector for detecting gases
04/03/2003WO2003027648A2 Compact multiwavelength phase fluorometer
04/03/2003WO2003027641A1 Module for extracting gas from underground liquid and installation equipped therewith
04/03/2003WO2003027639A2 Glucocorticoid receptor nuclear translocation domain
04/03/2003WO2003027638A2 Methods for detecting genetic mosaicisms using arrays
04/03/2003WO2003027637A2 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
04/03/2003WO2003027634A2 Identification of modulatory molecules using inducible promoters
04/03/2003WO2003027632A2 Use of isogenic human cancer cells for high-throughput screening and drug discovery
04/03/2003WO2003027631A2 Muscle sample prepared for prion assay
04/03/2003WO2003027328A2 Methods, kits and compositions pertaining to the suppression of detectable probe binding to randomly distributed repeat sequences in genomic nucleic acid
04/03/2003WO2003027326A2 Nucleic acid sequencing by raman monitoring of molecular deconstruction
04/03/2003WO2003027323A1 Genotyping kit for diagnosis of human papilloma virus infection
04/03/2003WO2003027322A2 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas
04/03/2003WO2003027319A1 Aptamers containing sequences of nucleic acids or nucleic acid analogues bound homologously, or in novel complexes
04/03/2003WO2003027317A2 Use of active substances for the prophylaxis and/or treatment of diseases caused by cell growth disturbances and test system for discovery of said active substances
04/03/2003WO2003027316A2 Methods of using 33751, a human potassium channel family member
04/03/2003WO2003027309A2 Diagnostic probe detection system
04/03/2003WO2003027307A2 Nucleic acid sequencing by raman monitoring of uptake of precursors during molecular replication
04/03/2003WO2003027288A1 Diagnostic method for cancer characterized in the detection of the deletion of g-csf exon 3
04/03/2003WO2003027287A1 Kidney-specific urate transporter and gene thereof
04/03/2003WO2003027285A1 Dna sequences for human angiogenesis genes
04/03/2003WO2003027284A1 Bone metablic disease markers and utilization thereof
04/03/2003WO2003027282A1 Adamts-15, -16, -17, -18 and -19
04/03/2003WO2003027281A2 Pluripotent stem cells originating in skeletal muscle intestinal tissue
04/03/2003WO2003027277A1 Method of screening reporgramming factor, reprogramming factor screened by the method, method of using the reprogramming factor, method of differentiating undifferentiated fused cells and method of constructing cell, tissues and organs
04/03/2003WO2003027264A2 Coisogenic eukaryotic cell collections
04/03/2003WO2003027263A2 Proteins associated with cell growth, differentiation, and death
04/03/2003WO2003027262A2 Biological discovery using gene regulatory networks generated from multiple-disruption expression libraries
04/03/2003WO2003027255A2 Anti-fusion assay
04/03/2003WO2003027252A2 Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods
04/03/2003WO2003027251A2 Novel molecules of the pyrin domain protein family and uses thereof
04/03/2003WO2003027250A2 Monoclonal antibodies to the drug tilmicosin and a method for detecting the same
04/03/2003WO2003027247A2 Modulation of stem cells using zinc finger proteins
04/03/2003WO2003027246A2 Antagonists
04/03/2003WO2003027239A2 Melanin-concentrating hormone receptor antagonist binding protein
04/03/2003WO2003027236A2 Systems, methods and kits for remote genetic analysis and consultation
04/03/2003WO2003027228A2 Receptors and membrane-associated proteins
04/03/2003WO2003027224A1 Optoinjection methods
04/03/2003WO2003027150A1 Antibody and use thereof
04/03/2003WO2003027149A1 Antibody and use of the same
04/03/2003WO2003027145A1 Cell death inducer, cells and animals expressing the same and method of screening anti-cell death remedy
04/03/2003WO2003027144A1 ENZYME PHOSPHORYLATING Ser46 OF p53
04/03/2003WO2003027143A2 Gene and protein relating to hepatocellular carcinoma
04/03/2003WO2003027142A1 Novel g protein-coupled receptor
04/03/2003WO2003027138A1 Search for cancer marker by novel screening method
04/03/2003WO2003027122A2 Lanthanide binding tags
04/03/2003WO2003026696A1 Method of controlling proliferation of cancer cells and cell death
04/03/2003WO2003026695A1 Agonists and antagonists of cylixin for the treatment of metabolic disorders
04/03/2003WO2003026670A2 Method for inhibiting the proliferation of hepatic stellate cells with a ligand of the low affinity glucocorticoid binding site (lags)
04/03/2003WO2003026660A1 An enantiomerically pure diarylmethylpiperazine and methods of using same
04/03/2003WO2003026590A2 Biological control of nanoparticles
04/03/2003WO2003026584A2 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
04/03/2003WO2003026573A2 Screening and selection methods for statin drug combinations
04/03/2003WO2003026566A2 Atlastin
04/03/2003WO2003026562A2 A crytallized complex of an eubacterium large ribosome subunit bound to an antibiotic
04/03/2003WO2003026561A2 Flavonoids for treatment of diabetes
04/03/2003WO2003026494A2 Galectins-1-and-4 in tumor development
04/03/2003WO2003026490A2 Methods and compositions for prevention, diagnosis, and treatment of cancer using bispecific molecules
04/03/2003WO2003026479A2 Methods of suppressing microglial activation
04/03/2003WO2003026445A1 Vitamin fortification of foodstuffs
04/03/2003WO2003026408A1 Model animal with overexpression of regucalcin
04/03/2003WO2003026398A2 V1a arginine vasopressin receptor disruptions, compositions and methods relating thereto
1 ... 2618 2619 2620 2621 2622 2623 2624 2625 2626 2627 2628 2629 2630 2631 2632 2633 2634 2635 2636 2637 2638 ... 3937